CA3251212A1 - DIRECTLY COMPRESSIBLE MANNITOL GRANULES - Google Patents

DIRECTLY COMPRESSIBLE MANNITOL GRANULES

Info

Publication number
CA3251212A1
CA3251212A1 CA3251212A CA3251212A CA3251212A1 CA 3251212 A1 CA3251212 A1 CA 3251212A1 CA 3251212 A CA3251212 A CA 3251212A CA 3251212 A CA3251212 A CA 3251212A CA 3251212 A1 CA3251212 A1 CA 3251212A1
Authority
CA
Canada
Prior art keywords
mannitol
egale
une
des
les
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3251212A
Other languages
English (en)
French (fr)
Inventor
Baptiste Boit
Antoine Salome
Fabrice Buquet
Philippe Lefevre
Nicolas TARLIER
Original Assignee
Roquette Freres SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR2201119A external-priority patent/FR3132522B1/fr
Application filed by Roquette Freres SA filed Critical Roquette Freres SA
Publication of CA3251212A1 publication Critical patent/CA3251212A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA3251212A 2022-02-08 2023-02-08 DIRECTLY COMPRESSIBLE MANNITOL GRANULES Pending CA3251212A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR2201119A FR3132522B1 (fr) 2022-02-08 2022-02-08 Granules de mannitol directement comprimable
FR2201119 2022-02-08
FR2211326 2022-10-28
FR2211326 2022-10-28
PCT/EP2023/025057 WO2023151868A1 (fr) 2022-02-08 2023-02-08 Granules de mannitol directement comprimables

Publications (1)

Publication Number Publication Date
CA3251212A1 true CA3251212A1 (en) 2023-08-17

Family

ID=85278534

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3251212A Pending CA3251212A1 (en) 2022-02-08 2023-02-08 DIRECTLY COMPRESSIBLE MANNITOL GRANULES

Country Status (8)

Country Link
US (1) US20250134816A1 (https=)
EP (1) EP4475821A1 (https=)
JP (1) JP2025505542A (https=)
KR (1) KR20240138086A (https=)
AU (1) AU2023217824A1 (https=)
CA (1) CA3251212A1 (https=)
MX (1) MX2024009496A (https=)
WO (1) WO2023151868A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3126683B2 (ja) * 1996-04-16 2001-01-22 武田薬品工業株式会社 Ｄ−マンニトールおよびその製造法
DE10161402A1 (de) * 2001-12-13 2003-06-18 Merck Patent Gmbh Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit
BRPI0914164B1 (pt) * 2008-06-20 2019-04-30 Merck Patent Gmbh Comistura para produção de comprimidos de desintegração rápida em um processo de formação de comprimido direto, seus usos, e formulações de comprimido
FR2944971B1 (fr) * 2009-04-30 2012-09-07 Roquette Freres Coagglomerats de mannitol et d'amidon granulaire comprimables et a ecoulement libre
FR3038836B1 (fr) * 2015-07-17 2017-07-14 Roquette Freres Granules de mannitol pour compression directe

Also Published As

Publication number Publication date
EP4475821A1 (fr) 2024-12-18
WO2023151868A1 (fr) 2023-08-17
US20250134816A1 (en) 2025-05-01
MX2024009496A (es) 2024-08-19
AU2023217824A1 (en) 2024-08-01
JP2025505542A (ja) 2025-02-28
KR20240138086A (ko) 2024-09-20

Similar Documents

Publication Publication Date Title
US8703203B2 (en) Oral dosage form of deferasirox
JP4707073B2 (ja) アトルバスタチン経口投与用粒子状医薬組成物
US20190125725A1 (en) Pharmaceutical compositions comprising brivaracetam
JP7586523B2 (ja) 改善されたブロモクリプチン製剤
US20130095177A1 (en) Method of preparing an oral dosage form comprising fingolimod
US20110189243A1 (en) Pharmaceutical formulation for lowering pulmonary blood pressure
Kim et al. Hydroxypropyl-β-cyclodextrin-based solid dispersed granules: a prospective alternative to conventional solid dispersion
JP2012041293A (ja) 乳酸菌又はその抽出成分を含有する口腔内崩壊錠
HUP0402006A2 (hu) Eljárás ibuprofen kristályok képzésére és ezek alkalmazása gyógyszerkészítmények előállítására
JP6164346B2 (ja) 口腔内崩壊錠の製造方法
CA3251212A1 (en) DIRECTLY COMPRESSIBLE MANNITOL GRANULES
CN110167552B (zh) 医药组合物及其制造方法
WO2016139683A2 (en) Pharmaceutical compositions of lurasidone and process for preparing the same
TW202014204A (zh) 含有崩解劑成分及微小纖維狀纖維素之崩解性固形物
US20090017122A1 (en) Drug Forms Having Controlled Bioavailability
EP2387993B1 (en) Orally disintegrating tablets of zolmitriptan and process for preparing the same
FR2940086A1 (fr) Formulation pharmaceutique de fenofibrate nanonise
CA2634879A1 (en) Pharmaceutical formulations of oxcarbazepine and methods for its preparation
US20030165566A1 (en) Sedative non-benzodiazepine formulations
US20160022661A1 (en) Dosage Form Comprising Crizotinib
Shinde et al. Fast-Dissolving Orodispersible Tablets: A Review
AU2003201155B2 (en) Sedative non-benzodiazepine formulations
FR3132522A1 (fr) Granules de mannitol directement comprimable
HK40008125A (en) Pharmaceutical composition
HK40007993B (en) Pharmaceutical composition

Legal Events

Date Code Title Description
A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A00-A101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - PCT

Effective date: 20240806

R00 Party data change recorded

Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R00-R113 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CHANGE OF ADDRESS OR METHOD OF CORRESPONDENCE REQUEST RECEIVED

Effective date: 20241022

Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R00-R116 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPOINTMENT OF AGENT REQUEST

Effective date: 20241022

Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R00-R119 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REVOCATION OF AGENT REQUEST

Effective date: 20241022

A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET

Effective date: 20250113

A15 Pct application entered into the national or regional phase

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250113

P18 Priority claim added or amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250113

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD

Year of fee payment: 2

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250131

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250131

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250131

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250304

R17 Change to representative recorded

Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R17-R121 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REVOCATION OF AGENT REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250305

Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R17-R117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPOINTMENT OF AGENT REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250305

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250305

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260121